Search
Menu
Home
HTB
2007
February
05
5 February 2007
Contents
Antiretrovirals
Pharmacokinetic study of Triomune-40 in Malawi: higher d4T exposure suggests importance of using lower dose formulations of d4T
GSK stops development of brecanavir
FDA analysis of predicted responses to tipranavir/r
Important changes to US prescribing information for efavirenz
Changes to US product label for T-20 (enfuvirtide)
Treatment access
Wall Street Journal examines reason Abbott increased price of ritonavir
Access to treatment in the USA: waiting list for ARVs in South Carolina
Royalty-free license granted for development of tenofovir and topical microbicide
Novartis test case in India threatens the ARV pharmacy of the developing world
Thailand issues compulsory license to manufacture lopinavir/r: WHO criticised for challenging this essential access to treatment
Global Fund Board selects new executive director
Women's health
Limited impact of immunosuppression and HAART on the incidence of cervical squamous intraepithelial lesions in HIV positive women
Hormonal contraception and the risk of HIV acquisition
Pregnancy
Response to nevirapine containing HAART following single dose nevirapine for PMTCT
Paediatric care
WHO paediatric recommendations
Masking the flavour of antiretrovirals in Thai children
Coinfections and complications
Elevated risk of lung cancer among people with AIDS
Hepatitis coinfection
Increased prevalence of cardiovascular disease among HIV-positive individuals coinfected with hepatitis C
Vaccines and microbicides
Two phase III HIV microbicide trials stopped due to increased transmission
On the web
Presentations from satellite sessions at ICCAC
Full text articles online
TB coinfection
IAVI report: 2006 Year in Review
HTB RSS
Early access
Kigala Call to Action: sign-on for IAS 2025 conference
1 July 2025
HIV organisations support trans and non-binary communities against the unworkable EHRC guidelines
30 June 2025
Long-acting injectable PrEP approved in the US: priced at $28,000 a year
28 June 2025
Clinical studies of two once-weekly pipeline compounds put on hold
27 June 2025
All early access reports
Current issues
July 2025
June 2025
May 2025
Back issues
Special report
Kigala Call to Action: sign-on for IAS 2025 conference
1 July 2025
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate